Extended-Release Intramuscular Paliperidone Palmitate

Onset of efficacy and tolerability following the initiation dosing of long-acting paliperidone palmitate: post-hoc analyses of a randomized, double-blind clinical trial

(2011) Cynthia A Bossie et al.   BMC Psychiatry

Changes in schizophrenia-related hospitalization and ER use among patients receiving paliperidone palmitate: results from a clinical trial with a 52-week open-label extension (OLE)

(2011) Chris M. Kozma et al.   CURRENT MEDICAL RESEARCH AND OPINION

A prospective randomized controlled trial of paliperidone ER versus oral olanzapine in patients with schizophrenia

(2011) Andreas Schreiner et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia

(2011) Huafang Li et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Effects of acute paliperidone palmitate treatment in subjects with schizophrenia recently treated with oral risperidone

(2011) Jennifer Kern Sliwa et al.   SCHIZOPHRENIA RESEARCH

Onset of efficacy with acute long-acting injectable paliperidone palmitate treatment in markedly to severely ill patients with schizophrenia: post hoc analysis of a randomized, double-blind clinical trial

(2011) Larry Alphs et al.   Annals of General Psychiatry

Paliperidone Extended Release

(2010) Claudine M. Chwieduk et al.   DRUGS

Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention

(2010) Ofer Agid et al.   EXPERT OPINION ON PHARMACOTHERAPY

Efficacy and safety of paliperidone palmitate in adult patients with acutely symptomatic schizophrenia: a randomized, double-blind, placebo-controlled, dose-response study

(2010) Srihari Gopal et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Strategies for Improving Treatment Adherence in Schizophrenia and Schizoaffective Disorder

(2010) Donald C. Goff et al.   JOURNAL OF CLINICAL PSYCHIATRY

A Randomized, Placebo-Controlled Study to Assess the Efficacy and Safety of 3 Doses of Paliperidone Palmitate in Adults With Acutely Exacerbated Schizophrenia

(2010) Gahan J. Pandina et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

A 52-week open-label study of the safety and tolerability of paliperidone palmitate in patients with schizophrenia

(2010) S Gopal et al.   JOURNAL OF PSYCHOPHARMACOLOGY

A Controlled, Evidence-Based Trial of Paliperidone Palmitate, A Long-Acting Injectable Antipsychotic, in Schizophrenia

(2010) Henry A Nasrallah et al.   NEUROPSYCHOPHARMACOLOGY

A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia

(2010) Gahan Pandina et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Second-generation antipsychotic long-acting injections: Systematic review

(2009) W. Wolfgang Fleischhacker   BRITISH JOURNAL OF PSYCHIATRY

Clinical guideline recommendations for antipsychotic long-acting injections

(2009) John M. Kane et al.   BRITISH JOURNAL OF PSYCHIATRY

Psychopharmacology and adverse effects of antipsychotic long-acting injections: A review

(2009) David Taylor   BRITISH JOURNAL OF PSYCHIATRY

Population Pharmacokinetics of Intramuscular Paliperidone Palmitate in Patients with Schizophrenia

(2009) Mahesh N. Samtani et al.   CLINICAL PHARMACOKINETICS

Practical guidance for dosing and switching paliperidone palmitate treatment in patients with schizophrenia

(2009) S. Gopal et al.   CURRENT MEDICAL RESEARCH AND OPINION

Paliperidone palmitate - review of the efficacy, safety and cost of a new second-generation depot antipsychotic medication

(2009) L. Citrome   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study

(2009) Michelle Kramer et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Safety and tolerability of deltoid and gluteal injections of paliperidone palmitate in schizophrenia

(2009) David Hough et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study

(2009) David Hough et al.   SCHIZOPHRENIA RESEARCH